Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Debt to Equity (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Debt to Equity for 11 consecutive years, with $0.31 as the latest value for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 2.49% to $0.31 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.31, a 2.49% increase, with the full-year FY2025 number at $0.31, up 2.49% from a year prior.
  • Debt to Equity was $0.31 for Q4 2025 at Ekso Bionics Holdings, roughly flat from $0.31 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.38 in Q4 2023 to a low of $0.05 in Q2 2021.
  • A 5-year average of $0.21 and a median of $0.28 in 2024 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: tumbled 92.28% in 2021, then surged 194.83% in 2023.
  • Ekso Bionics Holdings' Debt to Equity stood at $0.05 in 2021, then soared by 176.5% to $0.15 in 2022, then surged by 158.88% to $0.38 in 2023, then dropped by 20.87% to $0.3 in 2024, then grew by 2.49% to $0.31 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Debt to Equity are $0.31 (Q4 2025), $0.31 (Q3 2025), and $0.31 (Q2 2025).